142 related articles for article (PubMed ID: 37670337)
1. Safety and efficacy of P2Et extract from Caesalpinia spinosa in breast cancer patients: study protocol for a randomized double blind phase II clinical trial (CS003-BC).
Ballesteros-Ramírez R; Pinilla P; Sanchéz J; Torregrosa L; Aschner P; Urueña C; Fiorentino S
BMC Complement Med Ther; 2023 Sep; 23(1):309. PubMed ID: 37670337
[TBL] [Abstract][Full Text] [Related]
2. Standardized Extract from Caesalpinia spinosa is Cytotoxic Over Cancer Stem Cells and Enhance Anticancer Activity of Doxorubicin.
Sandoval TA; Urueña CP; Llano M; Gómez-Cadena A; Hernández JF; Sequeda LG; Loaiza AE; Barreto A; Li S; Fiorentino S
Am J Chin Med; 2016; 44(8):1693-1717. PubMed ID: 27852125
[TBL] [Abstract][Full Text] [Related]
3. Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from
Ballesteros-Ramírez R; Durán MI; Fiorentino S
Toxicol Rep; 2021; 8():258-263. PubMed ID: 33552924
[TBL] [Abstract][Full Text] [Related]
4. Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et).
Urueña C; Ballesteros-Ramírez R; Gomez-Cadena A; Barreto A; Prieto K; Quijano S; Aschner P; Martínez C; Zapata-Cardona MI; El-Ahanidi H; Jandus C; Florez-Alvarez L; Rugeles MT; Zapata-Builes W; Garcia AA; Fiorentino S
Front Med (Lausanne); 2022; 9():991873. PubMed ID: 36160152
[TBL] [Abstract][Full Text] [Related]
5. An Immunomodulatory Gallotanin-Rich Fraction From
Lasso P; Gomez-Cadena A; Urueña C; Donda A; Martinez-Usatorre A; Romero P; Barreto A; Fiorentino S
Front Immunol; 2020; 11():584959. PubMed ID: 33312174
[TBL] [Abstract][Full Text] [Related]
6. Safety Evaluation in Healthy Colombian Volunteers of P2Et Extract Obtained from
Duran MI; Ballesteros-Ramírez R; Tellez A; Torregrosa L; Olejua PA; Galvis S; Urueña C; Fiorentino S
Evid Based Complement Alternat Med; 2022; 2022():7943001. PubMed ID: 35251213
[TBL] [Abstract][Full Text] [Related]
7. Exploring the safety and efficacy of phytomedicine Petiveria alliacea extract (Esperanza) in patients with metastatic gastrointestinal tumors and acute leukemias: study protocol for a phase Ib/randomized double blind phase II trial (PA001).
Ballesteros-Ramírez R; Pinilla P; Sanchéz J; Arévalo M; Sanchez E; Aschner P; Urueña C; Fiorentino S
BMC Complement Med Ther; 2023 Aug; 23(1):284. PubMed ID: 37563608
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of chemotherapy and P2Et extract combination in ex-vivo derived tumor mammospheres from breast cancer patients.
Urueña C; Sandoval TA; Lasso P; Tawil M; Barreto A; Torregrosa L; Fiorentino S
Sci Rep; 2020 Nov; 10(1):19639. PubMed ID: 33184339
[TBL] [Abstract][Full Text] [Related]
9. Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model.
Urueña C; Mancipe J; Hernandez J; Castañeda D; Pombo L; Gomez A; Asea A; Fiorentino S
BMC Complement Altern Med; 2013 Apr; 13():74. PubMed ID: 23552194
[TBL] [Abstract][Full Text] [Related]
10. Encapsulated Phytomedicines against Cancer: Overcoming the "Valley of Death".
Brotons-Canto A; Urueña CP; Imbuluzqueta I; Luque-Michel E; Martinez-López AL; Ballesteros-Ramírez R; Rojas L; Fiorentino S
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111524
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional T Lymphocytes Generated After Therapy With an Antitumor Gallotanin-Rich Normalized Fraction Are Related to Primary Tumor Size Reduction in a Breast Cancer Model.
Urueña C; Gomez A; Sandoval T; Hernandez J; Li S; Barreto A; Fiorentino S
Integr Cancer Ther; 2015 Sep; 14(5):468-83. PubMed ID: 26220604
[TBL] [Abstract][Full Text] [Related]
13. Plant extract from
Jiménez MC; Prieto K; Lasso P; Gutiérrez M; Rodriguez-Pardo V; Fiorentino S; Barreto A
Heliyon; 2023 Mar; 9(3):e14148. PubMed ID: 36923867
[TBL] [Abstract][Full Text] [Related]
14. Natural Products Induce Different Anti-Tumor Immune Responses in Murine Models of 4T1 Mammary Carcinoma and B16-F10 Melanoma.
Lasso P; Rojas L; Arévalo C; Urueña C; Murillo N; Fiorentino S
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069022
[TBL] [Abstract][Full Text] [Related]
15. The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial.
You JS; Guo L; Huang M; Shi XL; Lin MD; Guo Z; Cao YL; Sun YZ; Xu Q; Qu WL; Liu HL; Chen JP
Trials; 2019 Dec; 20(1):719. PubMed ID: 31831051
[TBL] [Abstract][Full Text] [Related]
16. Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trial.
Newell M; Mackey JR; Bigras G; Alvarez-Camacho M; Goruk S; Ghosh S; Schmidt A; Miede D; Chisotti A; Postovit L; Baker K; Mazurak V; Courneya K; Berendt R; Dong WF; Wood G; Basi SK; Joy AA; King K; Meza-Junco J; Zhu X; Field C
BMJ Open; 2019 Sep; 9(9):e030502. PubMed ID: 31530611
[TBL] [Abstract][Full Text] [Related]
17. The delay in cell death caused by the induction of autophagy by P2Et extract is essential for the generation of immunogenic signals in melanoma cells.
Prieto K; Lozano MP; Urueña C; Alméciga-Díaz CJ; Fiorentino S; Barreto A
Apoptosis; 2020 Dec; 25(11-12):875-888. PubMed ID: 33156457
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic vs. Therapeutic Treatment With P2Et Polyphenol-Rich Extract Has Opposite Effects on Tumor Growth.
Lasso P; Gomez-Cadena A; Urueña C; Donda A; Martinez-Usatorre A; Barreto A; Romero P; Fiorentino S
Front Oncol; 2018; 8():356. PubMed ID: 30234017
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study.
Hashimoto D; Satoi S; Ishikawa H; Kodera Y; Kamei K; Hirano S; Fujii T; Uemura K; Tsuchida A; Yamada S; Yamamoto T; Hirota K; Sekimoto M
Trials; 2022 Feb; 23(1):135. PubMed ID: 35151367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
